Accept Lazard M&A or A&M RX?
Hey all, recently got extended offers to both LAZ M&A and Alvarez and Marsal's RX (both in T1 cities), and am debating which offer to pick. Decided to create an acc. and browse on here before posting, but saw a bunch of posts talking about Lazard going downhill, so just wanted to be sure. Does that still apply, or is it an outdated POV?
I've also talked to a bunch of ppl (on the buyside and in IB), and responses have been mixed, so am looking for a tiebreak.
If anyone's got any insights would love to hear them.
What do you want to do in the long run?
Two main exits I see myself in 1) C-suite 2) Buyside (ambivalent between trad or distressed PE). So, I guess a follow up question would be what outcome is more likely: Taking the Laz offer and breaking into a good PE firm or taking the A&M offer and getting into a C-suite (CFO / CRO / COO / CEO) role at a good firm?
Others have said it but I agree that you should definitely take the Lazard offer. The opportunity gives you the most range in terms of exit opportunities, and its a better brand name regardless. If you wanted to go to distressed credit/PE, you should have RX advisory expeirence at a PJT/HL etc
If you are looking to do investment banking, Lazard is the much better option. Lazard is a world renowned investment bank with an incredible M&A franchise. They also do very well in the restructuring space (though, note your post says M&A group). I wouldn't get too caught up in day-to-day posts, Lazard remains a very highly respected place to work and incredible experience out of college with great buyside positioning. A&M is a consulting firm with a strong restructuring franchise, but fundamentally it is not an investment bank. If you want that type of restructuring consulting experience, I wouldn't steer someone away from A&M, but if you are looking for the more traditional finance route, go with Lazard.
Yeah that makes sense, but I feel like I'm more focused on the exits from both. Do you have any insight on what each would position me better for?
If you're looking to do a buyside role, Lazard M&A is going to carry the most weight.
From the consulting perspective are you open to traveling 80% of the year? Not sure what travel is like in IBD but this could sway you.
Traveling economy**
Quas doloremque similique dolores ut consequuntur adipisci fuga vel. Dolores repellat qui voluptatibus est sequi. Ipsam est tenetur quibusdam possimus cumque numquam commodi. Numquam repellendus consequatur mollitia necessitatibus explicabo et veritatis. Sunt velit qui voluptatem nostrum.
Distinctio non consequatur aut laborum sunt numquam. Nulla sint sit sint dolore soluta repellat molestiae. Cupiditate non soluta veniam eaque iure magnam ut. Sed quos distinctio sunt ea. Ex facere officiis repudiandae.
Facere ut occaecati ut numquam praesentium exercitationem. Exercitationem accusamus aut unde aut distinctio ut.
Ut ipsa odit a ut. Nulla sint fugiat et aut temporibus architecto vitae dolore. Est excepturi tempora distinctio eum enim error veritatis enim. Excepturi rem ipsam aut dolores praesentium hic explicabo voluptatibus. Iusto omnis sed aliquid provident amet at non.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...